Karyopharm Therapeutics, Inc. (KPTIQ)
0.0255
+0.01
(+45.71%)
USD |
OTCM |
Nov 12, 16:00
Karyopharm Therapeutics Net Income (Annual) : -196.04M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -196.04M |
| December 31, 2024 | -76.42M |
| December 31, 2023 | -143.10M |
| December 31, 2022 | -165.29M |
| December 31, 2021 | -124.09M |
| December 31, 2020 | -196.27M |
| December 31, 2019 | -199.59M |
| December 31, 2018 | -178.41M |
| Date | Value |
|---|---|
| December 31, 2017 | -128.98M |
| December 31, 2016 | -109.58M |
| December 31, 2015 | -118.18M |
| December 31, 2014 | -75.78M |
| December 31, 2013 | -33.95M |
| December 31, 2012 | -15.89M |
| December 31, 2011 | -10.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Heron Therapeutics, Inc. | -20.20M |
| Tonix Pharmaceuticals Holding Corp. | -124.02M |
| Minerva Neurosciences, Inc. | -293.42M |
| Corbus Pharmaceuticals Holdings, Inc. | -78.54M |
| Ocugen, Inc. | -67.85M |